Quantitative Assessment of Blood Supply in the Gastic Conduit With Fluorescence Angiography for Esophageal Reconstruction
NCT04229524 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 246
Last updated 2020-06-09
Summary
A single-institution, randomize controlled trial is to be held to evaluate the correlation between blood supply in the gastic conduit and the incidence of anastomotic fistula during radical operation for esophageal squamous cell carcinoma by fluorescence angiography.
Conditions
Interventions
- PROCEDURE
-
Fluorescence angiography
After the tube and stomach were made during surgery, the predetermined anastomosis position was marked with sutures in advance according to the doctor's experience, and then 0.04ml / kg indocyanine green injection was injected into the central vein. Next, dynamic observation and recording of the tube-gastric anastomosis area in 136 seconds using a fluorescent imaging system with a fixed focal length till the fluorescence reaching range and intensity. If the average value of the fluorescence value of the anastomosis position is greater than 30, then the anastomosis position may be according to the original plan or moved to the proximal part. If the average fluorescence value of the predetermined anastomosis position is less than 30, the anastomosis must move to proximal part ensure anastomosis with fluorescence value at least\> 30.
Sponsors & Collaborators
-
Sichuan Cancer Hospital and Research Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2021-06-30
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma
NCT04380480 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus
NCT00766480 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
NCT06833775 ·Status: NOT_YET_RECRUITING
-
Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy
NCT03734952 ·Status: RECRUITING ·Phase: NA
-
Precisely Estimation of the Prognostic Value of Lymph Node in ESCC
NCT04764240 ·Status: COMPLETED
-
Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
NCT06421376 ·Status: RECRUITING ·Phase: PHASE2
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
NCT02938195 ·Status: UNKNOWN ·Phase: PHASE2
-
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523 ·Status: COMPLETED ·Phase: PHASE1
-
ctDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma
NCT05426850 ·Status: UNKNOWN
-
Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT02384811 ·Status: UNKNOWN ·Phase: PHASE2
-
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study
NCT05617352 ·Status: COMPLETED
-
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
NCT06556355 ·Status: COMPLETED
-
Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer
NCT01998230 ·Status: COMPLETED ·Phase: PHASE3
-
Improve the Treatment of Thoracic Esophageal Cancer
NCT01137123 ·Status: COMPLETED ·Phase: PHASE3
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NCT06602843 ·Status: RECRUITING ·Phase: NA
-
Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest
NCT00433524 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy
NCT05105945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
NCT06762158 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Application of 3T MRI in Esophageal Cancer
NCT03635619 ·Status: UNKNOWN
-
Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE
NCT02309619 ·Status: UNKNOWN ·Phase: NA
-
The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant Therapy
NCT07067359 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
NCT07046221 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2